Cylite Pty Ltd., was honoured to have two of its founders, Steve and Grant Frisken recognised in “The List – 100 Innovators 2021”.
The List: 100 Innovators 2021 is curated and edited by Technology Editor David Swan and draws on the knowledge and expertise of The Australian’s specialist journalists along with a world-class advisory panel.
“I was surprised and delighted to discover we were recognised in this way” stated Dr. Steve Frisken, Chief Executive Officer of Cylite. “It is an honour to be named alongside my brother and recognised in this list of talented entrepreneurs”, said Grant Frisken, Cylite’s Chief Technology Officer.
Both Steve and Grant commented, “there is a talented team of people, mostly based in Melbourne, who have continued give 100% throughout these challenging times, working on some very novel and innovative technologies that we believe will significantly advance medical care within the ophthalmic space. All of the team at Cylite can be proud of this recognition.”
Article extract: Cylite’s 4th-generation Hyperparallel-OCT device is a diagnostic tool for ophthalmologists and optometrists that uses 3D spectral imaging technology to measures full volume images of the eye at more than 300,000 A-scans per second. CEO Steve Frisken and CTO Grant Frisken have more than 40 years of experience between them and hold a number of patents. The device was the winner of the Australian Engineering Excellence Award, with Engineers Australia Victoria Division manager Alesha Printz describing it as “A cutting-edge technology that has been designed, engineered and manufactured in Australia.”
Full access to the article (needs subscription) https://www.theaustralian.com.au/business/top-innovators